Christopher P. Lowe - 28 Jun 2021 Form 4 Insider Report for Cortexyme, Inc. (QNCX)

Signature
/s/ Caryn McDowell, Attorney-in-Fact for Christopher Lowe
Issuer symbol
QNCX
Transactions as of
28 Jun 2021
Net transactions value
-$971,574
Form type
4
Filing time
30 Jun 2021, 17:46:35 UTC
Previous filing
14 May 2021
Next filing
30 Jun 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNCX Common Stock Options Exercise $44,600 +20,000 $2.23 20,000 28 Jun 2021 Direct
transaction QNCX Common Stock Sale $412,384 -7,724 -39% $53.39 12,276 28 Jun 2021 Direct F1, F2
transaction QNCX Common Stock Sale $383,186 -7,079 -58% $54.13 5,197 28 Jun 2021 Direct F1, F3
transaction QNCX Common Stock Sale $228,872 -4,153 -80% $55.11 1,044 28 Jun 2021 Direct F1, F4
transaction QNCX Common Stock Sale $58,631 -1,044 -100% $56.16 0 28 Jun 2021 Direct F1, F5
transaction QNCX Common Stock Options Exercise $66,900 +30,000 $2.23 30,000 30 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNCX Stock Option (right to buy) Options Exercise $0 -20,000 -8.5% $0.000000 215,594 28 Jun 2021 Common Stock 20,000 $2.23 Direct F6
transaction QNCX Stock Option (right to buy) Options Exercise $0 -30,000 -14% $0.000000 185,294 30 Jun 2021 Common Stock 30,000 $2.23 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.64 to $53.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.64 to $54.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.66 to $55.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.73 to $56.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F6 The option will vest as to 25% of the shares on November 15, 2019, with the remaining 75% of shares vesting in equal monthly installments beginning on December 15, 2019 and ending on November 15, 2022.